Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MD Labs is a private U.S. clinical laboratory company based in Reno, Nevada that provides patient monitoring toxicology and pharmacogenetic testing services for healthcare practices nationwide. The company operates as an independent reference laboratory and emphasizes high-complexity presumptive and confirmatory toxicology testing, as well as PGx testing with medication guidance. Its laboratory services are intended to help providers assess prescription adherence, detect potentially harmful drugs, and support treatment decisions with actionable reports. MD Labs uses technologies including UPLC-MS/MS/MS for confirmatory toxicology and RT-qPCR for molecular diagnostics. Rather than developing therapeutic drug candidates, the company is a commercial diagnostics and lab-services business serving clinicians across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MD Labs.